The NYC Health Department recently released the 2018 version of City Health Information (CHI): Diagnosing & Managing Hep C providing guidance to Primary Care Providers in hepatitis C screening, management and treatment.
Publications
The primary goals of the Manual are to increase advocates' knowledge about available HCV tests and treatments and to jumpstart discussions on advocacy strategies that can be used to open up affordable access for more people with HCV.
The American College of Physicians' High Value Care Task Force and the Centers for Disease Control and Prevention developed this article to present best practice statements for hepatitis B vaccination, screening, and linkage to care.
This study aims to validate algorithms designed to estimate treatment and cure of Hep C using RNA test results reported through routine surveillance.
On October 16, 2014, the fee-for-service (FFS) pharmacy program implemented clinical criteria for Hepatitis C Virus (HCV) drug therapy, as was recommended by the Drug Utilization Review Board (DURB) at the September 18, 2014 meeting. Included in this criteria were the following ...
This report presents an overview of the New York City Health Department’s 2015 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
In recognition of Liver Cancer Awareness Month, Gilead Sciences is excited to share that you can now watch BE ABOUT IT – the documentary highlighting the impact of chronic hep B on the Asian American community – on the Gilead YouTube channel!
Examining Hepatitis C Virus Treatment Access: A Review of Select State Medicaid Fee-For-Service and Managed Care Programs
Baby Boomers talk about the importance of getting tested for hepatitis C (Hep C) especially if you are born between 1945 and 1965.
Check out the Hep Free NYC 2016 Annual Report for an overview of the great work we did in 2016.
